搜索
雅培
ABT添加自选
114.140USD
-0.290-0.25%
收盘 08-20 16:00（美东）
197.61B总市值
31.69市盈率 TTM
关于 雅培 公司
雅培是一家横跨全球的医疗保健领导者，专注于多元健康产品的研发、制造与销售，业务框架涵盖四大单元：成熟药品、诊断、营养以及医疗器械。成熟药品单元负责多品牌仿制药的国际行销；诊断单元向血库、医院、商业实验室与替代护理点提供检测系统与试剂；营养单元经营成人及儿童营养品全球通路；医疗器械单元销售节律管理、电生理、心衰、血管、结构心脏、神经调控及糖尿病护理装置，持续推动创新改善患者生命品质。其全球供应链覆盖六大洲，利用数据分析与可持续制造提升效率与品质保障。
雅培 简介
公司代码ABT
公司名称Abbott Laboratories
上市日期Apr 06, 2073
CEOFord (Robert B)
员工数量114000
证券类型Ordinary Share
年结日Apr 06
公司地址100 Abbott Park Road
城市ABBOTT PARK
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编60064-3500
电话12246676100
网址https://www.abbott.com
公司代码ABT
上市日期Apr 06, 2073
CEOFord (Robert B)
雅培公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.75M
+0.18%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President and Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President and Group President - Established Pharmaceuticals and Nutritional Products
146.38K
-0.60%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
104.29K
-0.59%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President and Group President - Medical Devices
Executive Vice President and Group President - Medical Devices
90.41K
+20.44%
Mr. Christopher J. Scoggins
Mr. Christopher J. Scoggins
Executive Vice President - Diabetes Care
Executive Vice President - Diabetes Care
77.13K
+17.51%
Mr. Philip P. Boudreau
Mr. Philip P. Boudreau
Executive Vice President - Finance and Chief Financial Officer
Executive Vice President - Finance and Chief Financial Officer
71.54K
+28.74%
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
70.72K
-8.27%
Ms. Nancy McKinstry
Ms. Nancy McKinstry
Lead Independent Director
Lead Independent Director
41.01K
+5.57%
Dr. Robert J. Alpern, M.D.
Dr. Robert J. Alpern, M.D.
Independent Director
Independent Director
40.80K
--
Mr. Eric Shroff
Mr. Eric Shroff
Senior Vice President - Rapid and Molecular Diagnostics
Senior Vice President - Rapid and Molecular Diagnostics
39.16K
-1.81%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.75M
+0.18%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President and Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President and Group President - Established Pharmaceuticals and Nutritional Products
146.38K
-0.60%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
104.29K
-0.59%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President and Group President - Medical Devices
Executive Vice President and Group President - Medical Devices
90.41K
+20.44%
Mr. Christopher J. Scoggins
Mr. Christopher J. Scoggins
Executive Vice President - Diabetes Care
Executive Vice President - Diabetes Care
77.13K
+17.51%
Mr. Philip P. Boudreau
Mr. Philip P. Boudreau
Executive Vice President - Finance and Chief Financial Officer
Executive Vice President - Finance and Chief Financial Officer
71.54K
+28.74%
常见问题
雅培的前五大股东是谁？
雅培 的前五大股东如下：Mr. Daniel J. Starks
有多少机构持有雅培(ABT)的股份？
截至2026Q1，共有4859家机构持有雅培的股份，合计持有的股份价值约为1.25B，占公司总股份的71.75%。与2025Q4相比，机构持股有所增加，增幅为-187252308.00。
哪个业务部门对雅培的收入贡献最大？
在2026Q1，Diabetes Care业务部门对雅培的收入贡献最大，创收8.00B，占总收入的18.04%。